Quarter2 Report is near,....supermax,Topglove,harta,comfort,ruberex made crazy 4times to 8 times profit in quarter1.. when QR approach they go up like crazy probably because of insider got the news leak ahead of QR release... just remember Quarter 1 profit was crazy high (JAN,FEB,MARCH) that was before peak of covid19 in europe ,US, brazil,india etc. if you think QR1 was crazy imagine the QR2 profit for March,April,May? its not impossible for topglove to go up all the way to RM50
Offer for Rubberex not fair, not reasonable, says independent adviser
By Syafiqah Salim | theedgemarkets.com | 2020-07-23 10:31:25 KUALA LUMPUR (July 23): Minority shareholders of Rubberex Corp (M) Bhd have been advised to reject the takeover offer from chemical firm Hextar Global Bhd's executive director Datuk Ong Choo Meng and his 90%-held Hextar Rubber Sdn Bhd for the remaining Rubberex shares at RM1.80 apiece.
In a circular filed with Bursa Malaysia today, independent adviser MainStreet Advisers Sdn Bhd said the offer was “not fair and not reasonable”.
MainStreet Advisers said the offer price represents a discount ranging from 14 sen to RM1.25 to the five-day, one-month, three-month, six-month and one-year volume weighted average market prices (VWAPs) of Rubberex shares up to the last trading day (LTD).
“It also represents a discount of RM1.87 (50.95%), RM1.08 (37.50%) and RM1.77 (49.58%) to the five-day VWAP of the Rubberex shares up to the LPD (latest practicable date), the last transacted market price on the LTD and the last transacted market price of Rubberex shares on the LPD respectively,” it said.
It said Rubberex shares are relatively liquid as the average monthly trading liquidity of Rubberex shares of 14.32% is higher.
“Since Rubberex shares will remain traded on Bursa Securities, holders of Rubberex shares will therefore have the opportunity to dispose of their offer shares in the open market during the offer period and subsequent to the closing date at a price higher than the offer price, net of transaction cost.
"Based on the above and our evaluation as a whole, we are of the view that the offer is not fair and not reasonable. Accordingly, we recommend that the holders reject the offer," said Mainstreet Advisers.
To recap, Ong and Hextar had acquired an additional 20.63% stake in Rubberex, raising their collective interest to 50.18% — above the 33% threshold that triggers the mandatory general offer for the remaining shares they do not own in the company.
The stake, comprising 57.25 million shares, was bought at RM1.80 cash per share, or RM103.05 million in total, from Seng Sheng Enterprise Sdn Bhd, Datuk Seri Chiau Beng Teik and Peh Lian Hwa, via direct business transactions in June.
Post-acquisition, Ong and Hextar Rubber control 139.22 million shares in Rubberex, up from 81.97 million shares or 29.55% previously.
Ruberex vs Comfort TP RHB TP for Comfort at RM4.8, Comfort produced about 5.0b gloves p.a. with PUC of RM582.95m while Ruberex produced about 2.5b gloves with lower PUC of RM277.43m which is about half of Comfort. Mathematically, both company shall be having about the same EPS and thus Ruberex TP should also be RM4.8 and so I believe it still have room to go (today closing Comfort at RM4.28 vs Ruberex RM3.70). Note: This is for reference and not a recommendation to buy / sell and trading at your own risk. Good Luck all Ruberexian.
now then rubber has triggered a MGO where they have to improve the offer to the minority to complete the takeover.......perhaps double the original offer to make it 2.50 which is still below the current MV
Aramco No more cheap gloves stock after Carepls RM 2.63
Production capacity same as Comfort Rm4.33
Caprepls capacity will be more than Comfort 1-2 Billions by year end
Ruberex Glove capacity only 1 Billion RM 3.67 24/07/2020 10:58 AM
Goldberg WRP is currently controlled by a Private equity fund. They are looking at way to cash out and it could be thru a merger. This is the information that I have received. -------------------------------------------- Posted by desmondlee78 > Jul 24, 2020 10:17 AM | Report Abuse
Goldberg how solid are the WRP rumours? A merger with WRP would make Careplus a 20 billion glove capacity a year. That's a quarter of Top Glove capacity.
Carepls is the only cheapest Gloves stock in Bursa out of 7 stock Catch me while u can or else will be too late when explosive result out very soon Its will be the earliest to announce the result(as speculated)for QTR ended June Normally those who announce earlier result must be good , for example TG announce 10 days after QTR ended May (June 10th announce)
Note: Carepls just like a last Emperor of China (Emperor PuYI)
Actually if Shareholder (us) disagree that Hextar Ong proposal then ok ady ma.. Stupid Ong why offer RM1.80 ? He thought we are cheap prostitute ? As I know Ruberex at least worth RM7-RM8.
He over bought the rubberex share up to 50% more and trigger the mandatory take over rule, by bursa's SOP, he needs to make mandatory offer to all the minority, and of course if he offer a price, he needs to have the actual funds to buy all up ! I think he just "saja" offer according to procedure , who is so stupid to sell to him at that price ? End of the day the MO will fail, and the share price will continue to go up .... ! for sure !
bigprice KUALA LUMPURL: Glove maker Careplus Group Bhdturned a huge profit in second quarter ended June 30 boosted by strong demand worldwide for the protective gear.
The number of Covid-19 infection worldwide continue to accelerate this week, with total confirmed cases rising above the 15.5 million people mark.
Careplus said the global pandemic caused by the Covid-19 virus have created an exponential increase in demand for medical gloves which have benefited many manufacturers.
For the three-month ended June 30, revenue climbed 37% to RM118.9mil, while net profit soared to RM36.3mi, or 6.7 sen a share.
"The average selling prices have surged during the pandemic period which is expected to continue until vaccines have been developed and administered globally," Careplus said in a filing with Bursa Malaysia today.
It said while spot average selling price (ASP) remain high, the ASP for regular buyers is expected to increase in the coming quarter barring any significant change to current shortage of supply.
"The Group therefore expects strong positive results in this pandemic period and beyond," Careplus added.
Meanwhile, the worsening COVID-19 pandemic has accelerated the company's plan to increase the production capacity.
By end of this year, ten new production lines will be installed and commissioned, while another thirteen new production lines will be installed and commissioned next year.
"This will nearly double the total production capacity from 4.1 billion pieces to about 8.8 billion pieces by end of 2021 barring any interruption," Careplus said.
The Group will have a total of 50 production lines by end of 2021. 24/07/2020 9:00 PM
KUALA LUMPUR (June 22): Chemical firm Hextar Global Bhd's executive director Datuk Ong Choo Meng and his 90%-held Hextar Rubber Sdn Bhd have acquired an additional 20.63% stake in Rubberex, raising their collective interest to 50.18% – above the 33% threshold that triggers the mandatory general offer for the remainder shares they do not own in the company.
The stake, comprising 57.25 million shares, was bought at RM1.80 cash per share or RM103.05 million in total from Seng Sheng Enterprise Sdn Bhd, Datuk Seri Chiau Beng Teik and Peh Lian Hwa, via direct business transactions.
Notably, the purchase price is at a significant 38.4% discount from Rubberex's closing price of RM2.92 today. Year to date, Rubberex's share price has grown about six times from when it was trading at 54 sen apiece on Dec 31, 2019.
Post-acquisition, Ong and Hextar Rubber control 139.22 million shares in Rubberex, up from 81.97 million shares or 29.55% previously, according to the notice of unconditional MGO sent by the duo's representative, M&A Securities Sdn Bhd, and filed to Bursa Malaysia this evening.
As such, the duo or joint offerors are obliged to extend a mandatory takeover offer to acquire all the remaining 138.21 million Rubberex shares which are not already owned by them at the same RM1.80 per share, cash.
The offer is not conditional upon any minimum level of acceptances as they already hold more than 50% of the voting shares in Rubberex.
The offerors, however, intend to maintain the listing status of Rubberex on the Main Market of Bursa Malaysia.
Arsenewenger8383 Actual profit is 21 million.. our capacity is 4.1 billion gloves per annum.. we should expect $1 billion in revenue in 2020.. but we still too far behind.. Q1 Rev $105 mil, Q2 Rev $119mil.. Q3? Q4? Ermm... long way to go..
Aramco, this is rubberex forum, you have posted wrongly !!
DLLM99 ... simple logic, if Dato Ong is desperate to buy more rubberex shares, then most minority shareholders can gang up and hold UP the price and sell to him at RM4.50 then ! hehehe
hopefully careplus 's share price rise could also influence all other small cap glove counters to go up together !! Careplus 's QR up to June = 20 mils, Rubberex 's QR up to Mac (before crazy glove -ASP) = already 10 mils, so up to June QR = easily 30 mils !! I think Dato Ong knows about that, so he is trying to press down the price to collect at cheap before they announce latest QR !!
A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. Their Phase I/II trial, reported on July 20 in the journal Lancet, found that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in a Phase II/III trial in England, as well as Phase III trials in Brazil and South Africa. The project may deliver emergency vaccines by October. AstraZeneca has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses.
The German company BioNTech has entered into collaborations with Pfizer, based in New York, and the Chinese drug maker Fosun Pharma to develop their mRNA vaccine. In July, they posted preliminary results from their Phase I/II trials in the United States and Germany. They found that the volunteers produced antibodies against SARS-CoV-2, as well as immune cells called T cells that respond to the virus. Some volunteers experienced moderate side effects such as sleep disturbances and sore arms.
The company expects to start Phase III trials by the end of July. On July 22, the Trump administration awarded a $1.9 billion contract for 100 million doses to be delivered by December and the option to acquire 500 million more doses. If approved, Pfizer said they expect to manufacture over 1.3 billion doses of their vaccine by the end of 2021.
Vaccine could help, but is a long way off For those hoping to reopen the US after the coronavirus pandemic, vaccines have been a beacon of hope. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he believes that hope is warranted and that a vaccine could stop the pandemic in its tracks, but he also doesn't believe that will happen until well into 2021. The first Phase 3 coronavirus vaccine trial in the US is expected to begin next week. Here's how the vaccine works The first Phase 3 coronavirus vaccine trial in the US is expected to begin next week. Here's how the vaccine works "I think as we get into 2021, several months in, that you would have (a) vaccine that would be widely available to people in the United States," Fauci told the Washington Post's Bob Costa during a Post Live event. Fauci noted that some companies have said they could have a vaccine available before the end of the year. "I'm a little skeptical about that, but, you know, anything is possible," he told the Post. Once a vaccine is found and made available, the public will need to agree to take it in order for it to be effective. Former Centers for Disease Control and Prevention director Dr. Thomas Frieden said Friday that could be difficult. "This is the first time we've had an anti-vaccine movement before we've had the vaccine," Frieden said in a podcast sponsored by the online news site Axios. "There's already too much suspicion and hesitancy about vaccines, and the way to address that is to just say it like it is and be sure that we're saying what we're doing, when we're doing it, what we're learning, when we're learning it," said Frieden, who is now the president of Resolve to Save Lives.
it can not be ruled out that nominees could be used to accumulate shares in the open market.so be prepared for an unexpected surge in times to come.....
when the vaccine is in mass application all over the world, the demand for glove will even go higher as the world need even more gloves to deliver vaccine to even more human !!
Use your brain to think logically, nowadays gloves are used for medical front liners to handle covid-19 patients only, once vaccine in mass application, many many many x100000000000000000000000000 more gloves will be used for patients and non-patients (like you and me !!)
@Lewis Lee If you are a smart glove company investors, ignore those vaccine news but take caution on news of any development of giant glove factories in China !!
No cause of concern cos it is not easy to get certifications to be recognised internationally before these factories are allowed to export.their products are basically used locally in China..
This rubberex is the smallest pure glove maker in terms of market cap (1 bil) , even carplus rise up to 1.5 bil for the past few days ! It will catch up with all the other tai Kohs , sai Kohs soon .... !!
At one time Ruberex price matched with Comfort price but now Ruberex has left behind. Comfort already 4.20+ but Ruberex still at 3.70. Can Ruberex catch up with Comfort?
Actually, my research shows that rubberex's balance sheet is more solid and stable amongst all small cap glove stocks !! steady profit earnings, dividends, net cash 30 mils (can expand capacity anytime), most of their properties are valued at 1990s price !! (very under value in terms of NTA )
Just that they are a old company with most directors, managers over 60-70 yrs old, just do thing slowly steadily and do not keen on expanding like Top 4. that's why they sold all their shares to Datuk Ong & partners for retirement recently !!
Now Datuk Ong & partners aged 42 ++ , they will be keen to expand and grow the company aggressively !! and DAtuk Ong is also major shareholder in a listed chemical company , hope he an use his knowledge in chemistry to invent a break through technology gloves going forward , even can rival Harta (famous in innovate new products for glove ) , just my 2 cents !
Rubberex's EPS up to June, 20 shall be = 6 cent (easily, taking into account April-June crazy ASP) ! 6 x 4 = 24 cent annualized and forgot about the increase in ASP from July - Dec ! PE = 20, value = 20 x 24 = 4.80 PE = 30, value = 30 x 24 = 7.20
I only use PE 20-30, conservative figure again to compute the above conservative value !! (top 4 all use up to PE 40 to compute !!)
For careplus, actual EPS (minus "one off item") is 4 cents only (up to June , 20) , Rubberex up to March , 20 already can deliver 3.67 cts, so up to June,20, should be no problem to deliver EPS 6 cents !! My observation !
Careplus past results not that solid, and can run into huge losses but rubberex are well managed with almost no loss for past 10 years !! also no or minimal financial charges due to net cash position
i don't know why, but i feel like Rubberex have a long way to go..previously i thought their game will be over in very early of August..but never thought Rubberex can be this 'slow & steady' momentum & didn't try anything fancy that can lure in kaki goreng unlike comfort & careplus..this counter is very careful in each of their step..every step seems like fully calculated..i might be wrong but lets wait for their next QR
Just read the news Spain is experiencing swelling 2nd wave of covid 19, rubberex has a trading office in Spain (contributing around 20% of their revenue ) , would their Spain trading office sell gloves with higher margin or ASP ? ( just like Supermax) ??
Now Spain top the list in Europe for infected covid 19 cases ! They will rush to buy gloves at ANY costs !! Rubberex happened to be there to sell them !! Fellow investors pls take note !!
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 779 views | 13 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
JohnFarmer458
1,797 posts
Posted by JohnFarmer458 > 2020-07-23 09:35 | Report Abuse
red since monday,tuesday and wednesday, today and tomorrow will green , dont buy today tomorrow cant buy lower price already haha